Steroid-resistant rejection in kidney-transplanted patients: Is ATG treatment for three or ten days preferable?

Transplant International

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Olausson, Michael ^a   Mjörnstedt, Lars ^a   Brynger, Hans ^a   Blohmé, Ingemar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ATG; Kidney transplantation; Steroid resistant rejection

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029853649     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb01656.x     Document Type: Article

References (5)

1. Neuhaus P, Bechstein WO, Blumhardt G, Wiens M, Lemmens P, Langrehr JM, Lohmann R, Steffen R, Schlag H, Slama K-J, Lobeck H (1993) Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody. Transplantation 55: 1320-1327
2. Steininger R, Mühlbacher F, Hamilton G, Längle F, Gnant M, PopowT, Sautner T, Götzinger P, Wamser P, Stockenhuber F, Mirza D, Piza F (1991) Comparison of CyA, OKT3, and ATG immunoprophylaxis in human liver transplantation. Transplant Proc 23: 2269-2271
3. Birkeland SA (1975) A controlled clinical trial of treatment with ALG on established rejection of renal allografts. Acta Med Scand 198: 489
4. Abouna GM, Al-Abdullah IH, Kelly-Sullivan D, Kumar MSA, Loose J, Phillips K, Yost S, Seirka D (1995) Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring. Transplantation 59: 1564-1568
5. Bock HA, Gallati H, Zürcher RM, Bachofen M, Mihatsch MJ, Landman J, Thiel G (1995) A randomized prospective trial of prophylactic immunosuppression with ATG-Fresenius versus OKT3 after renal transplantation. Transplantation 59: 830-840